Determination of boron concentration in oilfield water with a microfluidic ion exchange resin instrument.

We developed and validated a microfluidic instrument for interference-free determination of boron in produced water. The instrument uses a boron-specific chelating resin to separate the analyte from its complex matrix. Ten produced water samples were analyzed with the instrument and the results were successfully validated against ICP-MS measurements. Removing interference effects enables precise boron measurement for wastewater even with high total dissolved solid (TDS) levels. 1,4-Piperazinediethanesulfonic acid conditions the resin and maintains the optimum pH for boron adsorption from the sample. Boron is then eluted from the resin using a 10% sulfuric acid solution and its concentration measured with the colorimetric carminic acid assay in 95% sulfuric acid. The use of a microfluidic mixer greatly enhances the sensitivity and kinetics of the carminic acid assay, by factors of 2 and 7.5, respectively, when compared against the same assay performed manually. A maximum sensitivity of 2.5mg(-1)L, a precision of 4.2% over the 0-40.0mgL(-1) measuring range, a 0.3mgL(-1) limit of detection, and a sampling rate of up to four samples per hour were achieved. Automation and microfluidics reduce the operator workload and fluid manipulation errors, translating into safer and higher-quality measurements in the field.

Determination of boron in produced water using the carminic acid assay.

Using the carminic acid assay, we determined the concentration of boron in oilfield waters. We investigated the effect of high concentrations of salts and dissolved metals on the assay performance. The influence of temperature, development time, reagent concentration, and water volume was studied. Ten produced and flowback water samples of different origins were measured, and the method was successfully validated against ICP-MS measurements. In water-stressed regions, produced water is a potential source of fresh water for irrigation, industrial applications, or consumption. Therefore, boron concentration must be determined and controlled to match the envisaged waste water reuse. Fast, precise, and onsite measurements are needed to minimize errors introduced by sample transportation to laboratories. We found that the optimum conditions for our application were a 5:1 mixing volume ratio (reagent to sample), a 1 g L(-1) carminic acid concentration in 99.99% sulfuric acid, and a 30 min reaction time at ambient temperature (20 °C to 23 °C). Absorption values were best measured at 610 nm and 630 nm and baseline corrected at 865 nm. Under these conditions, the sensitivity of the assay to boron was maximized while its cross-sensitivity to dissolved titanium, iron, barium and zirconium was minimized, alleviating the need for masking agents and extraction methods.

Twenty two cases of canine neural angiostrongylosis in eastern Australia (2002-2005) and a review of the literature

Cases of canine neural angiostrongylosis (NA) with cerebrospinal fluid (CSF) evaluations in the peer-reviewed literature were tabulated. All cases were from Australia. A retrospective cohort of 59 dogs was contrasted with a series of 22 new cases where NA was diagnosed by the presence of both eosinophilic pleocytosis and anti-Angiostrongylus cantonensis immunloglobulins (IgG) in CSF, determined by ELISA or Western blot. Both cohorts were drawn from south east Queensland and Sydney. The retrospective cohort comprised mostly pups presented for hind limb weakness with hyperaesthesia, a mixture of upper motor neurone (UMN) and lower motor neurone (LMN) signs in the hind limbs and urinary incontinence. Signs were attributed to larval migration through peripheral nerves, nerve roots, spinal cord and brain associated with an ascending eosinophilic meningo-encephomyelitis. The contemporary cohort consisted of a mixture of pups, young adult and mature dogs, with a wider range of signs including (i) paraparesis/proprioceptive ataxia (ii) lumbar and tail base hyperaesthesia, (iii) multi-focal central nervous system dysfunction, or (iv) focal disease with neck pain, cranial neuropathy and altered mentation. Cases were seen throughout the year, most between April and July (inclusive). There was a preponderance of large breeds. Often littermates, or multiple animals from the same kennel, were affected simultaneously or sequentially. A presumptive diagnosis was based on consistent signs, proximity to rats, ingestion/chewing of slugs or snails and eosinophilic pleocytosis. NA was diagnosed by demonstrating anti-A. cantonensis IgG in CSF. Detecting anti-A. cantonensis IgG in serum was unhelpful because many normal dogs (20/21 pound dogs; 8/22 of a hospital population) had such antibodies, often at substantial titres. Most NA cases in the contemporary series (19/22) and many pups (16/38) in the retrospective cohort were managed successfully using high doses of prednisolone and opioids. Treatment often included antibiotics administered in case protozoan encephalomyelitis or translocated bacterial meningitis was present. Supportive measures included bladder care and physiotherapy. Several dogs were left with permanent neural deficits. Dogs are an important sentinel species for NA. Human cases and numerous cases in tawny frogmouths were reported from the same regions as affected dogs over the study period.

Design and synthesis of potent, isoxazole-containing renin inhibitors.

The design and optimization of a novel isoxazole S(1) linker for renin inhibitor is described herein. This effort culminated in the identification of compound 18, an orally bioavailable, sub-nanomolar renin inhibitor even in the presence of human plasma. When compound 18 was found to inhibit CYP3A4 in a time dependent manner, two strategies were pursued that successfully delivered equipotent compounds with minimal TDI potential.

Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents.

An oral bioavailability issue encountered during the course of lead optimization in the renin program is described herein. The low F(po) of pyridone analogs was shown to be caused by a combination of poor passive permeability and gut efflux transport. Substitution of pyridone ring for a more lipophilic moiety (logD>1.7) had minimal effect on rMdr1a transport but led to increased passive permeability (P(app)>10 × 10(-6) cm/s), which contributed to overwhelm gut transporters and increase rat F(po). LogD and in vitro passive permeability determination were found to be key in guiding SAR and improve oral exposure of renin inhibitors.

Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.

The design and optimization of a novel series of renin inhibitor is described herein. Strategically, by committing the necessary resources to the development of synthetic sequences and scaffolds that were most amenable for late stage structural diversification, even as the focus of the SAR campaign moved from one end of the molecule to another, highly potent renin inhibitors could be rapidly identified and profiled.

Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.

An SAR campaign aimed at decreasing the overall lipophilicity of renin inhibitors such as 1 is described herein. It was found that replacement of the northern appendage in 1 with an N-methyl pyridone and subsequent re-optimization of the benzyl amide handle afforded compounds with in vitro and in vivo profiles suitable for further profiling. An unexpected CV toxicity in dogs observed with compound 20 led to the employment of a time and resource sparing rodent model for in vivo screening of key compounds. This culminated in the identification of compound 31 as an optimized renin inhibitor.

Complete disassembly of carbon disulfide by a ditantalum complex.

The side-on end-on dinitrogen complex [PhP(CH(2)SiMe(2)NPh)(2)Ta](µ-H)(2)(µ-η(2):η(1)-N(2)) reacts with CS(2) with complete cleavage of both C=S double bonds and the formation of [PhP(CH(2)SiMe(2)NPh)(2)Ta](µ-S)(2)(µ-CH(2)), which has two bridging sulfides and a bridging methylene unit. Further reaction with H(2) produces CH(4) and the disulfide complex.

Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case study.

Time-dependent inhibitors of CYPs have the potential to perpetrate drug-drug interactions in the clinical setting. After finding that several leading compounds in a novel series of substituted amino propanamide renin inhibitors inactivated CYP3A4 in an NADPH-dependent and time-dependent manner, a search to identify the cause of this liability was initiated. Extensive SAR revealed that the amide bridge present in compound 1 as a possible culprit. Through the installation of a metabolic soft spot distal to this moiety, potent renin inhibitors with improved CYP profile were identified.

Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.

The discovery and SAR of a new series of substituted amino propanamide renin inhibitors are herein described. This work has led to the preparation of compounds with in vitro and in vivo profiles suitable for further development. Specifically, challenges pertaining to oral bioavailability, covalent binding and time-dependent CYP 3A4 inhibition were overcome thereby culminating in the identification of compound 50 as an optimized renin inhibitor with good efficacy in the hypertensive double-transgenic rat model.

The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor.

The discovery of novel and selective inhibitors of human 5-lipoxygenase (5-LO) is described. These compounds are potent, orally bioavailable, and active at inhibiting leukotriene biosynthesis in vivo in a dog PK/PD model. A major focus of the optimization process was to reduce affinity for the human ether-a-go-go gene potassium channel while preserving inhibitory potency on 5-LO. These efforts led to the identification of inhibitor (S)-16 (MK-0633, setileuton), a compound selected for clinical development for the treatment of respiratory diseases.

From life insurance to safer sex--reflections of a marketing man.

Much of the writing on health in developing countries focuses on the public sector rather than the private market, and on providers rather than on consumers. A more consumer-oriented perspective would regard the transactions by which most people in most poor countries buy healthcare as the norm, just one among many purchases of a personal service which all of us, as consumers, have to make. This paper contends that asymmetric information is not confined to health and medicine, but is a common problem for consumers whatever the GDP of the country they live in, and however rich and poor they may be. Understanding how consumers overcome these problems yields insights into the ways in which providers have to market their services, and into what, if anything, governments and donors can do to extend, improve or regulate the private healthcare market.

Inner-sphere two-electron reduction leads to cleavage and functionalization of coordinated dinitrogen.

Activation of molecular nitrogen by transition metal complexes is an area of current interest as investigations using the inert N2 molecule to produce higher-value organonitrogen compounds intensify. In an attempt to extend the addition of hydride reagents E-H (where E = BR2, AlR2, and SiR3) to the dinitrogen complex ([NPN]Ta)2(mu-H)2(mu-eta1:eta2-N2) [1; where NPN = (PhNSiMe2CH2)2PPh], the reaction with zirconocene chlorohydride, [Cp2Zr(Cl)H]x, was examined. The crystalline product formed in 35% yield was determined to be ([NP(N)N]Ta)(mu-H)2(mu-N)(Ta[NPN])(ZrCp2) (2) in which the coordinated N2 has been cleaved to form a phosphinimide bridging between Ta and Zr and a triply bridging nitride. The mechanism of this reaction was examined to determine the fate of the chloride and hydride ligands attached to Zr in the starting zirconocene reagent. Using the zirconocene dihydride dimer ([Cp2ZrH2]2), a higher yield of 2 was obtained (76%), and H2 was also observed by 1H NMR spectroscopy. To probe the origin of the eliminated H2, the dideuterated dinitrogen complex ([NPN]Ta)2(mu-D)2(mu-eta1:eta2-N2) (d2-1) was allowed to react with ([Cp2ZrH2]2), which resulted in the formation of ([NP(N)N]Ta)(mu-D)2(mu-N)(Ta[NPN])(ZrCp2), (d2-2), with no evidence of hydrogen for deuterium scrambling between the starting zirconocene dihydride and the ditantalum dinitrogen complex. Studies into the use of preformed Zr(II) and Ti(II) reagents were also performed. The proposed mechanism involves initial adduct formation that facilitates inner-sphere electron transfer to cleave the N-N bond to form a species with bridging nitrides, one of which is transformed by nucleophilic attack of a phosphine donor to generate the observed phosphinimide.

Substituent effects in the hydrosilylation of coordinated dinitrogen in a ditantalum complex: cleavage and functionalization of N2.

The dinitrogen complex ([NPN]Ta)2(mu-eta1:eta2-N2)(mu-H)2, 1, (where [NPN] = (PhNSiMe2CH2)2PPh) undergoes hydrosilylation with primary and secondary alkyl- and arylsilanes, giving a new N-Si bond and a new terminal tantalum hydride derived from one Si-H unit. Various primary silanes can be employed to give isolable complexes of the general formula ([NPN]TaH)(mu-N-N-SiH(n)R(3-n))(mu-H)2(Ta[NPN]) (5, R=Bu, n = 2; 9, R=Ph, n = 2). Analogous complexes featuring secondary silanes are not isolable, because these products, and 5 and 9, are uniformly unstable toward reductive elimination of bridging hydrides as H2, followed by cleavage of the N-N bond to give ([NPN]TaH)(mu-N)(mu-N-SiH(n)R(3-n))(Ta[NPN]) (6, R=Bu, n = 2; 10, R=Ph, n = 2; 15, R=Ph, n = 1; 16, R=Ph and Me, n = 1). The bridging nitrido ligand in these complexes is itself a substrate for a second hydrosilylation when n = 2, and schemes leading to Ta(IV) complexes of the general formula ([NPN]Ta)2(mu-N-SiH2R)(mu-N-SiH2R') via elimination of H2 are reported (4, R=R'=Bu; 12, R=Bu, R' = Ph; 13, R=Bu, R' = CH2CH2SiH3). At this point, the general reaction manifold for these compounds ramifies, with distinct outcomes occurring for different R groups-[NPN] ligand amide migration from Ta to RSi affords 11, whereas stable complex 6 rearranges to give 7, in the presence of excess silane. Ethanediylbissilane reacts with 1 to give 14, isostructural to 7.

N-N splitting of a functionalized mu-eta1:eta2 coordinated N2 ligand leading to a micro-nitrido micro-imido core: mechanistic insight from DFT.

Silylation of a dinuclear tantalum complex containing a side-on end-on coordinated dinitrogen ligand initiates a sequence of reactions ultimately leading to a bis(micro-imido) structure. DFT is employed to determine the energetics of the entire reaction cascade. Particular emphasis is put on the unprecedented N-N cleavage reaction of the functionalized, micro-eta1:eta2 coordinated dinitrogen ligand. A mechanism for this reaction is derived theoretically and the corresponding transition state is determined.

Lewis adducts of the side-on end-on dinitrogen-bridged complex [{(NPN)Ta}2(mu-H)2(mu-eta 1:eta 2-N2)] with AlMe3, GaMe3, and B(C6F5)3: synthesis, structure, and spectroscopic properties.

Reaction of the side-on end-on dinitrogen complex [{(NPN)Ta}(2)(mu-H)(2)(mu-eta(1):eta(2)-N(2))] (1; in which NPN=(PhNSiMe(2)CH(2))(2)PPh), with the Lewis acids XR(3) results in the adducts [{(NPN)Ta}(2)(mu-H)(2)(mu-eta(1):eta(2)-NNXR(3))], XR(3)=GaMe(3) (2), AlMe(3) (3), and B(C(6)F(5))(3) (4). The solid-state molecular structures of 2, 3, and 4 demonstrate that the N-N bond length increases relative to those found in 1 by 0.036, 0.043, and 0.073 A, respectively. In solution complexes 2-4 are fluxional as evidenced by variable-temperature (1)H NMR spectroscopy. The (15)N{(1)H} NMR spectra of 2-4 are reported; furthermore, their vibrational properties and electronic structures are evaluated. The vibrational structures are found to be closely related to that of the parent complex 1. Detailed spectroscopic analysis on 2-4 leads to the identification of the theoretically expected six normal modes of the Ta(2)N(2) core. On the basis of experimental frequencies and the QCB-NCA procedure, the force constants are determined. Importantly, the N-N force constant decreases from 2.430 mdyn A(-1) in 1 to 1.876 (2), 1.729 (3), and 1.515 mdyn A(-1) (4), in line with the sequence of N-N bond lengths determined crystallographically. DFT calculations on a generic model of the Lewis acid adducts 2-4 reveal that the major donor interaction between the terminal nitrogen atom and the Lewis acid is mediated by a sigma/pi hybrid molecular orbital of N(2), corresponding to a sigma bond. Charge analysis performed for the adducts indicates that the negative charge on the terminal nitrogen atom of the dinitrogen ligand increases with respect to 1. The lengthening of the N-N bond observed for the Lewis adducts is therefore explained by the fact that charge donation from the complex fragment into the pi* orbitals of dinitrogen is increased, while electron density from the N-N bonding orbitals p(sigma) and pi(h) is withdrawn due to the sigma interaction with the Lewis acid.

Spectroscopic properties and quantum chemistry-based normal coordinate analysis (QCB-NCA) of a dinuclear tantalum complex exhibiting the novel side-on end-on bridging geometry of N2: correlations to electronic structure and reactivity.

The vibrational properties and the electronic structure of the side-on end-on N(2)-bridged Ta complex ([NPN]Ta(micro-H))(2)(micro-eta(1):eta(2)-N(2)) (1) (where [NPN] = (PhNSiMe(2)CH(2))(2)PPh) are analyzed. Vibrational characterization of the Ta(2)(micro-N(2))(micro-H)(2) core is based on resonance Raman and infrared spectroscopies evaluated with a novel quantum chemistry-based normal coordinate analysis (QCB-NCA). The N-N stretching frequency is found at 1165 cm(-)(1) exhibiting a (15)N(2) isotope shift of -37 cm(-)(1). Four other modes of the Ta(2)N(2)H(2) core are observed between 430 and 660 cm(-)(1). Two vibrations of the bridging hydrido ligands are also identified in the spectra. On the basis of experimental frequencies and the QCB-NCA procedure, the N-N force constant is determined to be 2.430 mdyn A(-)(1). The Ta-N force constants are calculated to be 2.517 mdyn A(-)(1) for the Ta-eta(1)-N(2) bond and 1.291 and 0.917 mdyn A(-)(1) for the Ta-eta(2)-N(2) bonds, respectively. DFT calculations on 1 suggest that the bridging dinitrogen ligand carries a charge of -1.1, which is equally distributed over the two nitrogen atoms. However, orbital analysis reveals that the terminal nitrogen makes lower contributions to the pi orbitals and much higher contributions to the pi orbitals of the N(2) ligand than the bridging nitrogen. This suggests that reactions of the dinitrogen ligand with electrophiles should preferentially occur at the terminal N atom, in agreement with experimental results.

Hydrosilylation of a dinuclear tantalum dinitrogen complex: cleavage of N2 and functionalization of both nitrogen atoms.

Hydrosilylation of the ditantalum dinitrogen complex ([NPN]Ta)2(mu-H)2(mu-eta1:eta2-N2) proceeds via an addition reaction to produce ([NPN]TaH)(mu-H)2(mu-eta1:eta2-N-NSiH2Bu)(Ta[NPN]), which contains a new N-Si bond and a terminal tantalum hydride; this species has been characterized by NMR spectroscopy and X-ray diffraction. This complex undergoes reductive elimination of H2 followed by N-N bond cleavage to generate a new intermediate with the formula ([NPN]TaH)(mu-N)(mu-NSiH2Bu)(Ta[NPN]); confirmation of N-N bond cleavage is evident from the 15N-labeled isotopomer that displays an absence of 15N-15N scalar coupling in the 15N NMR spectrum. In the presence of additional silane, a second hydrosilylation and reductive elimination results to give ([NPN]Ta)2(mu-NSiH2Bu)2, a species in which each dinitrogen-derived N atom has been converted to a bridging silylimide ligand. This latter complex displays C2h symmetry both in solution and in the solid state.